Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 71 (9), 677-84

The Placebo Treatments in Neurosciences: New Insights From Clinical and Neuroimaging Studies


The Placebo Treatments in Neurosciences: New Insights From Clinical and Neuroimaging Studies

Nico J Diederich et al. Neurology.


Placebo (PL) treatment is a method utilized as a control condition in clinical trials. A positive placebo response is seen in up to 50% of patients with Parkinson disease (PD), pain syndromes, and depression. The response is more pronounced with invasive procedures or advanced disease. Physiologic and biochemical changes have been studied in an effort to understand the mechanisms underlying placebo-related clinical improvement. In PD, objective clinical improvements in parkinsonism correlate with dopaminergic activation of the striatum, documented by PET and with changes in cell firings of the subthalamic nucleus documented by single cell recordings. Dopaminergic pathways mediating reward may underlie PL-mediated improvement in PD. In pain syndromes, endogenous opioid release triggered by cortical activation, especially the rostral anterior cingulated cortex, is associated with PL-related analgesia and can be reversed by opioid antagonists. Covert treatment of an analgesic is less effective than overt treatment, suggesting an expectation component to clinical response. In depression, PL partially imitates selective serotonin reuptake inhibitor-mediated brain activation. Diseases lacking major "top-down" or cortically based regulation may be less prone to PL-related improvement.

Comment in

Similar articles

  • Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease
    SC Lidstone et al. Arch Gen Psychiatry 67 (8), 857-65. PMID 20679593.
    The strength of belief of improvement can directly modulate dopamine release in patients with PD. Our findings demonstrate the importance of uncertainty and/or salience o …
  • Placebo Mechanisms and Reward Circuitry: Clues From Parkinson's Disease
    R de la Fuente-Fernández et al. Biol Psychiatry 56 (2), 67-71. PMID 15231437. - Review
    Recent evidence indicates that the placebo effect in Parkinson's disease is mediated by the release of dopamine in the dorsal striatum. Interestingly, there is also place …
  • The Placebo-Reward Hypothesis: Dopamine and the Placebo Effect
    R de la Fuente-Fernández. Parkinsonism Relat Disord 15 Suppl 3, S72-4. PMID 20083013.
    Based on the observation that the placebo effect in Parkinson's disease was mediated by the release of endogenous dopamine in both the dorsal and ventral striatum, in 200 …
  • Neuroimaging Study of Placebo Analgesia in Humans
    YH Qiu et al. Neurosci Bull 25 (5), 277-82. PMID 19784082. - Review
    Placebo has been reported to exert beneficial effects in patients regarding the treatment of pain. Human functional neuroimaging technology can study the intact human bra …
  • Neurobiological Mechanisms of Placebo Responses
    JK Zubieta et al. Ann N Y Acad Sci 1156, 198-210. PMID 19338509. - Review
    Expectations, positive or negative, are modulating factors influencing behavior. They are also thought to underlie placebo effects, potentially impacting perceptions and …
See all similar articles

Cited by 31 PubMed Central articles

See all "Cited by" articles

MeSH terms